567 results on '"Lohoff, Falk W."'
Search Results
52. Genetic Variation in the Vesicular Monoamine Transporter 1 (VMAT1/SLC18A1) Gene and Alcohol Withdrawal Severity
53. Association analysis between polymorphisms in the myo-inositol monophosphatase 2 ( IMPA2) gene and bipolar disorder
54. Smoking is significantly associated with increased risk of COVID-19 and other respiratory infections
55. Genetic Variation in PADI6-PADI4 on 1p36.13 Is Associated with Common Forms of Human Generalized Epilepsy
56. Genetic and neurophysiological biomarkers of neuroplasticity inform post-stroke language recovery
57. Variability in cTBS Aftereffects Attributed to the Interaction of Stimulus Intensity With BDNF Val66Met Polymorphism
58. Additional file 1 of Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging
59. Additional file 5 of Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging
60. Additional file 6 of Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging
61. Additional file 4 of Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging
62. Additional file 3 of Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging
63. Genetic variation in PADI6-PADI4 on 1p36.13 is associated with common forms of human generalized epilepsy
64. Fear conditioning and extinction in alcohol dependence: Evidence for abnormal amygdala reactivity
65. Overview of the Genetics of Major Depressive Disorder
66. Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release
67. Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety disorder
68. Individual differences in the morphometry and activation of time perception networks are influenced by dopamine genotype
69. Neural correlates of attentional bias for smoking cues: modulation by variance in the dopamine transporter gene
70. The Dopamine Receptor D2 (DRD2) SNP rs1076560 is Associated with Opioid Addiction
71. Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder
72. Clinical predictors of non‐response to lithium treatment in the Pharmacogenomics of Bipolar Disorder (PGBD) study
73. The Genetic Liability for Pain Medication Usage and Risk for Major Depressive Disorder: A Multivariable Mendelian Randomization Analysis
74. PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use Disorder
75. Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking
76. Prescription opioid use and risk for major depressive disorder:a multivariable Mendelian randomization analysis
77. A genetically-informed study disentangling the relationships between tobacco smoking, cannabis use, alcohol consumption, substance use disorders and respiratory infections, including COVID-19
78. Epigenetics of alcohol use disorder—A review of recent advances in DNA methylation profiling
79. Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders
80. Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis
81. Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder
82. Genetics of Mood Disorders
83. Genetics of Bipolar Disorder
84. Genetic Variants in the Vesicular Monoamine Transporter 1 (VMAT1/SLC18A1) and Neuropsychiatric Disorders
85. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions
86. The future of psychiatric pharmacogenomics
87. Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort
88. Pharmacotherapies and personalized medicine for alcohol use disorder: a review
89. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
90. Epigenome-wide association study and multi-tissue replication of individuals with alcohol use disorder: evidence for abnormal glucocorticoid signaling pathway gene regulation
91. Adverse Childhood Experiences are Associated with High-Intensity Binge Drinking Behavior in Adulthood and Mediated by Psychiatric Disorders
92. Educational attainment reduces the risk of suicide attempt among individuals with and without psychiatric disorders independent of cognition: a multivariable Mendelian randomization study with more than 815,000 participants
93. Lack of association between variations in the brain-derived neurotrophic factor (BDNF) gene and temporal lobe epilepsy
94. No association between common variations in the neuronal nicotinic acetylcholine receptor alpha2 subunit gene (CHRNA2) and bipolar I disorder
95. Lack of association between single nucleotide polymorphisms in the corticotropin releasing hormone receptor 1 (CRHR1) gene and alcohol dependence
96. Pharmacogenetics of Major Depressive Disorder
97. Analysis of a Quantitative Trait Locus for Seizure Susceptibility in Mice Using Bacterial Artificial Chromosome-Mediated Gene Transfer
98. Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence
99. Fine mapping of a seizure susceptibility locus on mouse Chromosome 1: nomination of Kcnj10 as a causative gene
100. Epigenome-wide association study of alcohol consumption in N= 8161 individuals and relevance to alcohol use disorder pathophysiology: identification of the cystine/glutamate transporter SLC7A11 as a top target
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.